Ruane, Cunniff & Goldfarb
Streaks
2 names have been in this book every quarter on record (53). New in this book this quarter: ROP, BAC, HGV, VT.
Over time
Filings
- Q2 2026 filed Aug 13, 26 $6.4B · 54 positions · 4 new · 0 exited full · Concentrated 4 new · 0 exited
- Q1 2026 filed May 14, 26 $6.0B · 50 positions · 4 new · 2 exited full · Concentrated 4 new · 2 exited
- Q4 2025 filed Feb 12, 26 $6.4B · 48 positions · 4 new · 3 exited full · Concentrated 4 new · 3 exited
- Q3 2025 filed Nov 13, 25 $6.0B · 47 positions · 7 new · 3 exited full · Concentrated 7 new · 3 exited
- Q2 2025 filed Aug 13, 25 $5.8B · 43 positions · 6 new · 1 exited full · Concentrated 6 new · 1 exited
- Q1 2025 filed May 14, 25 $5.5B · 38 positions · 2 new · 3 exited full · Concentrated 2 new · 3 exited
- Q4 2024 filed Feb 13, 25 $5.9B · 39 positions · 3 new · 1 exited full · Concentrated 3 new · 1 exited
- Q3 2024 filed Nov 13, 24 $6.4B · 37 positions · 2 new · 2 exited full · Concentrated 2 new · 2 exited
- Q2 2024 filed Aug 13, 24 $6.4B · 37 positions · 3 new · 0 exited full · Concentrated 3 new · 0 exited
- Q1 2024 filed May 14, 24 $6.4B · 34 positions · 1 new · 0 exited full · Concentrated 1 new · 0 exited
- Q4 2023 filed Feb 13, 24 $6.3B · 33 positions · 1 new · 4 exited full · Concentrated 1 new · 4 exited
- Q3 2023 filed Nov 13, 23 $6.0B · 36 positions · 5 new · 3 exited full · Concentrated 5 new · 3 exited
- Q2 2023 filed Aug 11, 23 $6.3B · 34 positions · 3 new · 0 exited full · Concentrated 3 new · 0 exited
- Q1 2023 filed May 12, 23 $6.1B · 31 positions · 2 new · 3 exited full · Concentrated 2 new · 3 exited
- Q4 2022 filed Feb 13, 23 $6.4B · 32 positions · 2 new · 1 exited full · Concentrated 2 new · 1 exited
- Q3 2022 filed Nov 14, 22 $6.7B · 31 positions · 2 new · 2 exited full · Concentrated 2 new · 2 exited
- Q2 2022 filed Aug 15, 22 $7.7B · 31 positions · 0 new · 3 exited full · Concentrated 0 new · 3 exited
- Q1 2022 filed May 13, 22 $10.2B · 34 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q4 2021 filed Feb 11, 22 $11.7B · 34 positions · 1 new · 0 exited full · Concentrated 1 new · 0 exited
- Q3 2021 filed Nov 12, 21 $11.1B · 33 positions · 2 new · 4 exited full · Concentrated 2 new · 4 exited
- Q2 2021 filed Aug 13, 21 $11.3B · 35 positions · 0 new · 2 exited full · Concentrated 0 new · 2 exited
- Q1 2021 filed May 14, 21 $10.6B · 37 positions · 6 new · 7 exited full · Focused 6 new · 7 exited
- Q4 2020 filed Feb 12, 21 $9.4B · 38 positions · 4 new · 1 exited full · Concentrated 4 new · 1 exited
- Q3 2020 filed Nov 13, 20 $8.4B · 35 positions · 2 new · 4 exited full · Concentrated 2 new · 4 exited
- Q2 2020 filed Aug 14, 20 $7.5B · 37 positions · 1 new · 2 exited full · Concentrated 1 new · 2 exited
- Q1 2020 filed May 15, 20 $6.2B · 38 positions · 3 new · 4 exited full · Concentrated 3 new · 4 exited
- Q4 2019 filed Feb 14, 20 $8.1B · 39 positions · 2 new · 3 exited full · Concentrated 2 new · 3 exited
- Q3 2019 filed Nov 13, 19 $7.6B · 40 positions · 5 new · 2 exited full · Concentrated 5 new · 2 exited
- Q2 2019 filed Aug 14, 19 $7.4B · 37 positions · 3 new · 17 exited full · Concentrated 3 new · 17 exited
- Q1 2019 filed May 15, 19 $9.8B · 51 positions · 1 new · 7 exited full · Concentrated 1 new · 7 exited
- Q4 2018 filed Feb 13, 19 $9.1B · 57 positions · 8 new · 12 exited full · Concentrated 8 new · 12 exited
- Q3 2018 filed Nov 14, 18 $10.9B · 61 positions · 4 new · 4 exited full · Concentrated 4 new · 4 exited
- Q2 2018 filed Aug 14, 18 $11.2B · 61 positions · 7 new · 6 exited full · Concentrated 7 new · 6 exited
- Q1 2018 filed May 14, 18 $10.9B · 60 positions · 7 new · 13 exited full · Concentrated 7 new · 13 exited
- Q4 2017 filed Feb 13, 18 $12.2B · 66 positions · 4 new · 7 exited full · Focused 4 new · 7 exited
- Q3 2017 filed Nov 13, 17 $11.4B · 69 positions · 4 new · 5 exited full · Focused 4 new · 5 exited
- Q2 2017 filed Aug 11, 17 $10.8B · 70 positions · 2 new · 20 exited full · Focused 2 new · 20 exited
- Q1 2017 filed May 12, 17 $10.6B · 88 positions · 9 new · 13 exited full · Focused 9 new · 13 exited
- Q4 2016 filed Feb 13, 17 $10.6B · 92 positions · 12 new · 20 exited full · Focused 12 new · 20 exited
- Q3 2016 filed Nov 14, 16 $10.7B · 100 positions · 4 new · 21 exited full · Focused 4 new · 21 exited
- Q2 2016 filed Jul 15, 16 $10.5B · 117 positions · 8 new · 24 exited full · Concentrated 8 new · 24 exited
- Q1 2016 filed May 16, 16 $12.9B · 133 positions · 13 new · 23 exited full · Concentrated 13 new · 23 exited
- Q4 2015 filed Feb 16, 16 $17.6B · 143 positions · 4 new · 11 exited full · Concentrated 4 new · 11 exited
- Q3 2015 filed Nov 16, 15 $19.5B · 150 positions · 14 new · 13 exited full · Very concentrated 14 new · 13 exited
- Q2 2015 filed Aug 14, 15 $21.0B · 149 positions · 3 new · 10 exited full · Very concentrated 3 new · 10 exited
- Q1 2015 filed May 15, 15 $21.1B · 156 positions · 7 new · 7 exited full · Very concentrated 7 new · 7 exited
- Q4 2014 filed Feb 17, 15 $19.6B · 156 positions · 9 new · 14 exited full · Concentrated 9 new · 14 exited
- Q3 2014 filed Nov 14, 14 $18.9B · 161 positions · 18 new · 7 exited full · Concentrated 18 new · 7 exited
- Q2 2014 filed Aug 14, 14 $18.7B · 150 positions · 12 new · 6 exited full · Concentrated 12 new · 6 exited
- Q1 2014 filed May 15, 14 $18.7B · 144 positions · 6 new · 5 exited full · Concentrated 6 new · 5 exited
- Q4 2013 filed Feb 14, 14 $18.0B · 143 positions · 8 new · 12 exited full · Concentrated 8 new · 12 exited
- Q3 2013 filed Nov 14, 13 $16.8B · 147 positions · 12 new · 13 exited full · Concentrated 12 new · 13 exited
- Q2 2013 filed Aug 14, 13 $15.5B · 148 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited





